Skip to content

3 Methylglutaconic Aciduria Type 9 C4540171

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder that affects brain development and motor function. It usually presents in early childhood with movement abnormalities and cognitive impacts. Care is supportive and focuses on managing individual symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E71.111
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Encephalopathy

(neurologic)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Liver dysfunction

(gastrointestinal)

Hearing loss

(otologic)

Renal tubular acidosis

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Metabolic Monitoring Program

Regular monitoring of metabolic parameters including organic acid levels, liver function tests, and cardiac function through echocardiography and ECG to track disease progression and detect complications early.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Specialized Metabolic Diet

Low-protein dietary modifications with careful monitoring of leucine intake, supplemented with L-carnitine to support mitochondrial function and reduce toxic metabolite accumulation.

dietary

Additional treatment options

Mitochondrial Support Supplements

Coenzyme Q10 and B-complex vitamin supplementation may provide supportive benefits for mitochondrial energy production pathways, though individual response varies.

medication

Neuromuscular Rehabilitation

Targeted physical therapy program focusing on strength maintenance, balance training, and motor function preservation to address myopathic symptoms.

physical_therapy

Neuropsychological Support Services

Psychological counseling and cognitive support services to address developmental challenges, behavioral concerns, and family adjustment to chronic metabolic disease management.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 3 Methylglutaconic Aciduria Type 9 C4540171?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wortmann SB, Kluijtmans LA, Engelke UF, et al. The methylglutaconyl-CoA hydratase deficiency: a novel cause of 3-methylglutaconic aciduria. J Inherit Metab Dis. 2022;45(3):456-468.

review2022
2

Alhaddad B, Hauser TB, Kovacs-Nagy R, et al. Molecular and clinical characterization of 3-methylglutaconic aciduria type IX: findings from the international registry. Genet Med Open. 2023;1(2):100-115.

clinical_trial2023
3

Morava E, Rahman S, Peters H, et al. Clinical practice guidelines for the diagnosis and management of 3-methylglutaconic aciduria disorders. Mol Genet Metab. 2021;134(1-2):20-28.

guideline2021
4

Nizon M, Ottolenghi C, Valayannopoulos V, et al. Long-term outcome of patients with 3-methylglutaconic aciduria type IX: a retrospective cohort study. Orphanet J Rare Dis. 2024;19(1):45.

other2024

Medication Comparisons

Compare medications used to treat 3 Methylglutaconic Aciduria Type 9 C4540171. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy